Alternative routes of drug administration: exposure of imatinib using different formulations
Cancer Chemotherapy and Pharmacology · 2025
DOI: 10.1007/s00280-025-04766-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von H B Fiebrich-Westra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, Isala Hospital, Zwolle, The Netherlands. Hauptthemen laut MEDLINE: Antineoplastic Agents, Benzamides, Gastrointestinal Stromal Tumors, Piperazines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Medical Oncology, Isala Hospital, Zwolle, The Netherlands.
- Department of Surgical Oncology, Isala Hospital, Zwolle, The Netherlands.
- Department of Clinical Pharmacy, Isala Hospital, Dr. van Heesweg 2, Zwolle, 8025AB, The Netherlands. E.J.Smolders@isala.nl.
Zitieren
APA
Fiebrich-Westra, H. B., Visser, O., Francken, A. B., & Smolders, E. J. (2025). Alternative routes of drug administration: exposure of imatinib using different formulations. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-025-04766-9
Vancouver
Fiebrich-Westra HB, Visser O, Francken AB, Smolders EJ. Alternative routes of drug administration: exposure of imatinib using different formulations. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-025-04766-9
BibTeX
@article{FiebrichWestra2025,
author = {Fiebrich-Westra, H B and Visser, O and Francken, A B and Smolders, E J},
title = {Alternative routes of drug administration: exposure of imatinib using different formulations},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2025},
doi = {10.1007/s00280-025-04766-9}
}
EUVIMED